2023-504259-29-00已完成4 期
Bioequivalence of Ulipristal 30 mg Tablets in Healthy Subjects Under Fed Conditions
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 44
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Amparo Amilburu
Scientific
Laboratorios Leon Farma S.A.
研究点 (1)
Loading locations...
相似试验
尚未招募
4 期
se of a drug named as Ulipristal for managing the benign tumor of uterus of women who donot want operatioCTRI/2017/06/008942College of Medicine and JNM Hospital50
尚未招募
不适用
Bioequivalence Study of Rosuvastatin 40 mg in Healthy Thai Volunteers under Fasting ConditionsBioequivalence of generic rosuvastatinTCTR20170322003All Research Co., Ltd.42
尚未招募
不适用
To Compare the Efficacy Of Tablet Ulipristal Acetate with inj GnRH agonist in Women with Fibroid UterusCTRI/2016/10/007336ot Applicable64
进行中（未招募）
不适用
ulipristal acetate in the management of fibroid uterusCTRI/2020/03/024325sangam jha
招募中
Unknown
Bioequivalence study of Lansoprazole 30 mg capsuleThis study is performed on healthy volunteers..IRCT20200623047902N40Actover Co24